Sökning: WFRF:(Rubin J.) > Epithelioid hemangi...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 09152naa a2201429 4500 | |
001 | oai:lup.lub.lu.se:14ce555d-70c8-4c79-a869-0b207a20c1c2 | |
003 | SwePub | |
008 | 211220s2021 | |||||||||||000 ||eng| | |
024 | 7 | a https://lup.lub.lu.se/record/14ce555d-70c8-4c79-a869-0b207a20c1c22 URI |
024 | 7 | a https://doi.org/10.1016/j.esmoop.2021.1001702 DOI |
040 | a (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a for2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Stacchiotti, S.u Istituto Nazionale dei Tumori4 aut |
245 | 1 0 | a Epithelioid hemangioendothelioma, an ultra-rare cancer : a consensus paper from the community of experts |
264 | 1 | b Elsevier BV,c 2021 |
520 | a Epithelioid hemangioendothelioma (EHE) is an ultra-rare, translocated, vascular sarcoma. EHE clinical behavior is variable, ranging from that of a low-grade malignancy to that of a high-grade sarcoma and it is marked by a high propensity for systemic involvement. No active systemic agents are currently approved specifically for EHE, which is typically refractory to the antitumor drugs used in sarcomas. The degree of uncertainty in selecting the most appropriate therapy for EHE patients and the lack of guidelines on the clinical management of the disease make the adoption of new treatments inconsistent across the world, resulting in suboptimal outcomes for many EHE patients. To address the shortcoming, a global consensus meeting was organized in December 2020 under the umbrella of the European Society for Medical Oncology (ESMO) involving >80 experts from several disciplines from Europe, North America and Asia, together with a patient representative from the EHE Group, a global, disease-specific patient advocacy group, and Sarcoma Patient EuroNet (SPAEN). The meeting was aimed at defining, by consensus, evidence-based best practices for the optimal approach to primary and metastatic EHE. The consensus achieved during that meeting is the subject of the present publication. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
653 | a diagnosis | |
653 | a epithelioid hemangioendothelioma | |
653 | a guidelines | |
653 | a management | |
653 | a sarcoma | |
653 | a treatment | |
700 | 1 | a Miah, A. B.u Institute of Cancer Research London4 aut |
700 | 1 | a Frezza, A. M.u Istituto Nazionale dei Tumori4 aut |
700 | 1 | a Messiou, C.u Institute of Cancer Research London4 aut |
700 | 1 | a Morosi, C.u Istituto Nazionale dei Tumori4 aut |
700 | 1 | a Caraceni, A.u Istituto Nazionale dei Tumori4 aut |
700 | 1 | a Antonescu, C. R.u Memorial Sloan-Kettering Cancer Center4 aut |
700 | 1 | a Bajpai, J.u Homi Bhabha National Institute4 aut |
700 | 1 | a Baldini, E.u Brigham and Women's Hospital / Harvard Medical School4 aut |
700 | 1 | a Bauer, S.u University Hospital Essen4 aut |
700 | 1 | a Biagini, R.u National Cancer Institute Regina Elena4 aut |
700 | 1 | a Bielack, S.u Klinikum Stuttgart Olgahospital4 aut |
700 | 1 | a Blay, J. Y.u Claude Bernard University Lyon 14 aut |
700 | 1 | a Bonvalot, S.u PSL University4 aut |
700 | 1 | a Boukovinas, I.u NORDIX4 aut |
700 | 1 | a Bovee, J. V.M.G.u Leiden University Medical Centre4 aut |
700 | 1 | a Boye, K.u Norwegian Radium Hospital4 aut |
700 | 1 | a Brodowicz, T.u Medical University of Vienna4 aut |
700 | 1 | a Callegaro, D.u Istituto Nazionale dei Tumori4 aut |
700 | 1 | a De Alava, E.u University of Seville,University Hospital Virgen del Rocío4 aut |
700 | 1 | a Deoras-Sutliff, M.u The EHE Foundation4 aut |
700 | 1 | a Dufresne, A.u Claude Bernard University Lyon 14 aut |
700 | 1 | a Eriksson, M.u Lund University,Lunds universitet,Medicinsk onkologi,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Medical oncology,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,LUCC: Lund University Cancer Centre,Other Strong Research Environments4 aut0 (Swepub:lu)onk-mer |
700 | 1 | a Errani, C.u Rizzoli Orthopedic Institute4 aut |
700 | 1 | a Fedenko, A.u P.A. Hertzen Moscow Oncology Research Institute4 aut |
700 | 1 | a Ferraresi, V.u National Cancer Institute Regina Elena4 aut |
700 | 1 | a Ferrari, A.u Istituto Nazionale dei Tumori4 aut |
700 | 1 | a Fletcher, C. D.M.u Brigham and Women's Hospital / Harvard Medical School4 aut |
700 | 1 | a Garcia del Muro, X.u Catalan Institute of Oncology4 aut |
700 | 1 | a Gelderblom, H.u Leiden University Medical Centre4 aut |
700 | 1 | a Gladdy, R. A.u University of Toronto4 aut |
700 | 1 | a Gouin, F.u Centre Léon Bérard4 aut |
700 | 1 | a Grignani, G.u Institute for Cancer Research and Treatment, Candiolo4 aut |
700 | 1 | a Gutkovich, J.u NYU Langone,The EHE Foundation4 aut |
700 | 1 | a Haas, R.u Antoni Van Leeuwenhoek Hospital,Leiden University Medical Centre4 aut |
700 | 1 | a Hindi, N.u University of Seville4 aut |
700 | 1 | a Hohenberger, P.u Heidelberg University4 aut |
700 | 1 | a Huang, P.u Institute of Cancer Research London4 aut |
700 | 1 | a Joensuu, H.u Helsinki University Central Hospital4 aut |
700 | 1 | a Jones, R. L.u Institute of Cancer Research London4 aut |
700 | 1 | a Jungels, C.u Institut Jules Bordet4 aut |
700 | 1 | a Kasper, B.u Heidelberg University4 aut |
700 | 1 | a Kawai, A.u National Cancer Center Hospital, Japan4 aut |
700 | 1 | a Le Cesne, A.u Institut Gustave Roussy4 aut |
700 | 1 | a Le Grange, F.u University College London Hospital4 aut |
700 | 1 | a Leithner, A.u Medical University of Graz4 aut |
700 | 1 | a Leonard, H.4 aut |
700 | 1 | a Lopez Pousa, A.u Hospital de Sant Pau4 aut |
700 | 1 | a Martin Broto, J.u Hospital Fundación Jiménez Díaz4 aut |
700 | 1 | a Merimsky, O.u Tel-Aviv University4 aut |
700 | 1 | a Merriam, P.u Dana-Farber Cancer Institute4 aut |
700 | 1 | a Miceli, R.u Istituto Nazionale dei Tumori4 aut |
700 | 1 | a Mir, O.u Institut Gustave Roussy4 aut |
700 | 1 | a Molinari, M.u University of Pittsburgh Medical Center4 aut |
700 | 1 | a Montemurro, M.u Lausanne University Hospital4 aut |
700 | 1 | a Oldani, G.u Geneva University Hospital4 aut |
700 | 1 | a Palmerini, E.u Rizzoli Orthopedic Institute4 aut |
700 | 1 | a Pantaleo, M. A.u St. Orsola-Malpighi University Hospital4 aut |
700 | 1 | a Patel, S.u University of Texas4 aut |
700 | 1 | a Piperno-Neumann, S.u Curie Institute, Paris4 aut |
700 | 1 | a Raut, C. P.u Brigham and Women's Hospital / Harvard Medical School,Harvard Medical School4 aut |
700 | 1 | a Ravi, V.u University of Texas4 aut |
700 | 1 | a Razak, A. R.A.u University of Toronto4 aut |
700 | 1 | a Reichardt, P.u HELIOS Klinikum Berlin-Buch4 aut |
700 | 1 | a Rubin, B. P.u Cleveland Clinic Foundation4 aut |
700 | 1 | a Rutkowski, P.u The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology4 aut |
700 | 1 | a Safwat, A. A.u Aarhus University Hospital4 aut |
700 | 1 | a Sangalli, C.u Istituto Nazionale dei Tumori4 aut |
700 | 1 | a Sapisochin, G.u University of Toronto4 aut |
700 | 1 | a Sbaraglia, M.u University Hospital of Padua4 aut |
700 | 1 | a Scheipl, S.u Medical University of Graz4 aut |
700 | 1 | a Schöffski, P.u Leuven Cancer Institute4 aut |
700 | 1 | a Strauss, D.u Institute of Cancer Research London4 aut |
700 | 1 | a Strauss, S. J.u University College London Hospital4 aut |
700 | 1 | a Sundby Hall, K.u Norwegian Radium Hospital4 aut |
700 | 1 | a Tap, W. D.u Memorial Sloan-Kettering Cancer Center4 aut |
700 | 1 | a Trama, A.u Istituto Nazionale dei Tumori4 aut |
700 | 1 | a Tweddle, A.u Royal Marsden Hospital, London4 aut |
700 | 1 | a van der Graaf, W. T.A.u Antoni Van Leeuwenhoek Hospital4 aut |
700 | 1 | a Van De Sande, M. A.J.u Leiden University Medical Centre4 aut |
700 | 1 | a Van Houdt, W.u Antoni Van Leeuwenhoek Hospital4 aut |
700 | 1 | a van Oortmerssen, G.u Leiden University4 aut |
700 | 1 | a Wagner, A. J.u Dana-Farber Cancer Institute4 aut |
700 | 1 | a Wartenberg, M.u Sarcoma Patients EuroNet (SPAEN)4 aut |
700 | 1 | a Wood, J.u Royal Marsden NHS Foundation Trust4 aut |
700 | 1 | a Zaffaroni, N.u Istituto Nazionale dei Tumori4 aut |
700 | 1 | a Zimmermann, C.u University of Toronto4 aut |
700 | 1 | a Casali, P. G.u Istituto Nazionale dei Tumori4 aut |
700 | 1 | a Dei Tos, A. P.u University Hospital of Padua4 aut |
700 | 1 | a Gronchi, A.u Istituto Nazionale dei Tumori4 aut |
710 | 2 | a Istituto Nazionale dei Tumorib Institute of Cancer Research London4 org |
773 | 0 | t ESMO Opend : Elsevier BVg 6:3q 6:3x 2059-7029 |
856 | 4 | u http://dx.doi.org/10.1016/j.esmoop.2021.100170x freey FULLTEXT |
856 | 4 | u http://www.esmoopen.com/article/S2059702921001307/pdf |
856 | 4 8 | u https://lup.lub.lu.se/record/14ce555d-70c8-4c79-a869-0b207a20c1c2 |
856 | 4 8 | u https://doi.org/10.1016/j.esmoop.2021.100170 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy